Home | Contact | Site Map
Investor Relations - Press Releases
About Advantek Biologics
Research & Development
Products & Solutions
Investor Relations
Investors & Sponsors
In the News



6 March 2007
Advantek 's Patent on Method for Making Alpha-1-Protease Inhibitor Granted by the Chinese State Intellectual Property Office

1 August 2006
Advantek Filed for Registration of Human Immunoglobulin in Philippines

22 March 2006
Advantek received the Licence for Manufacturer and the Certificate for Manufacturer

27 July 2003
Shenzhen-Hong Kong Consortium Successfully Developed SARS Hyperimmune Globulins (Human) for the Treatment of Patients of Future SARS Outbreaks a Completed National 863 Project

13 February 2003
Gradipore Announces Agreement with Hong Kong Advantek Biologics for Application of Gradiflow Technology for Biosafety of Plasma Fractions
SARS Antiserum (Horse)

©2003 Advantek Biologics Limited Disclaimer